Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New research indicates proportion of young women who have never been screened for cervical cancer more than doubled since 2005
Developed by a British firm, the test will be available as a $29 add-on to pricier genetic profiling assays
Clinical laboratories may soon be able to use a simplified LDL cholesterol calculation
The technology has moved from niche to practical for routine diagnostics
The two assays identify threats prior to prostate cancer being diagnosed and after it has undergone extensive treatment, respectively
AMP Annual Meeting attendees showed strong interest in the blood test
SimplyTest’s saliva-based HPV tests will be marketed to dentists and functional medicine practices
Platform enhances the interpretability of CBC-based machine-learning models
The assay detects the presence of three different proteins and is slightly more accurate than a test Quest released earlier this year
Current assays often miss diagnoses in the early stages of the disease, delaying treatment
The initiative is in conjunction with The Gift of Life registry and Doublemint Gum
FDA-approved tests like Intellisep and TriVerity demonstrate potential for early sepsis diagnosis
Clinical lab professionals will want to note the pros and cons each technology brings
